ZKW-19152-60538
3 vaccinations
3 coded responses
37 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 618 / IL
- Registered
- 2021-10-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-10-25
Dose 1 — Pfizer-BioNTech
-
2021-10-26
Registered in v-safe
- 2021-10-26
- 2021-10-27
-
2021-10-28
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-29
- 2021-10-30
- 2021-10-31
-
2021-11-01
Health check-in — day 7, dose 1Feeling: Poor · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-08
-
2021-11-15
Dose 2 — Pfizer-BioNTech
- 2021-11-15
-
2021-11-16
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-17
- 2021-11-18
- 2021-11-19
- 2021-11-20
- 2021-11-21
- 2021-11-22
- 2021-11-29
- 2021-12-06
- 2021-12-15
- 2021-12-20
- 2021-12-27
-
2022-02-14
Survey response — 3 months, dose 2MedDRA: Upper respiratory tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Upper respiratory infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-02-14
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-18
Call successfulNot applicable - Accidental Reporting
-
2022-05-02
Dose 3 — Pfizer-BioNTech
- 2022-05-02
-
2022-05-03
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-05-04
- 2022-05-05
- 2022-05-07
- 2022-05-08
- 2022-05-09
- 2022-05-16
-
2022-05-23
Survey response — day 21, dose 3MedDRA: Mastitis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: MastitisMedDRA releases: 2024-11 · check-in free text available
-
2022-05-23
Report sent to call center — day 21, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-24
- 2022-05-24
- 2022-05-30
- 2022-06-06
- 2022-06-13
- 2022-08-01
- 2022-10-31
-
2023-05-02
Survey response — 12 months, dose 3MedDRA: Cough, Oropharyngeal pain — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-10-25 | Pfizer-BioNTech | No |
| 2 | 2021-11-15 | Pfizer-BioNTech | No |
| 3 | 2022-05-02 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-14 | Successful 2022-02-18 |
Not applicable - Accidental Reporting |
| 2022-05-23 | Unsuccessful |
Free text
Release 11 — 3 months, dose 2
Symptoms: Upper respiratory infection
Release 11 — day 21, dose 3
Symptoms: Mastitis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Mastitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release